289 related articles for article (PubMed ID: 20600450)
1. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance.
Fury W; Tremoulet AH; Watson VE; Best BM; Shimizu C; Hamilton J; Kanegaye JT; Wei Y; Kao C; Mellis S; Lin C; Burns JC
Hum Immunol; 2010 Sep; 71(9):865-73. PubMed ID: 20600450
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
Ogihara Y; Ogata S; Nomoto K; Ebato T; Sato K; Kokubo K; Kobayashi H; Ishii M
Pediatr Res; 2014 Sep; 76(3):287-93. PubMed ID: 24964229
[TBL] [Abstract][Full Text] [Related]
3. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
4. [Biomarkers associated with unresponsiveness to IVIG in children with Kawasaki disease].
Abe J; Matsuda A
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(1):27-34. PubMed ID: 23445729
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
6. Gene-expression patterns reveal underlying biological processes in Kawasaki disease.
Popper SJ; Shimizu C; Shike H; Kanegaye JT; Newburger JW; Sundel RP; Brown PO; Burns JC; Relman DA
Genome Biol; 2007; 8(12):R261. PubMed ID: 18067656
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
[TBL] [Abstract][Full Text] [Related]
8. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
Ogata S; Shimizu C; Franco A; Touma R; Kanegaye JT; Choudhury BP; Naidu NN; Kanda Y; Hoang LT; Hibberd ML; Tremoulet AH; Varki A; Burns JC
PLoS One; 2013; 8(12):e81448. PubMed ID: 24324693
[TBL] [Abstract][Full Text] [Related]
9. Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone.
Ogata S; Ogihara Y; Nomoto K; Akiyama K; Nakahata Y; Sato K; Minoura K; Kokubo K; Kobayashi H; Ishii M
Pediatr Res; 2009 Nov; 66(5):577-84. PubMed ID: 19680167
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG.
Mortazavi SH; Amin R; Alyasin S; Kashef S; Karimi MH; Babaei M; Younesi V
Iran J Allergy Asthma Immunol; 2015 Apr; 14(2):188-97. PubMed ID: 25780885
[TBL] [Abstract][Full Text] [Related]
11. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
Wang Z; Xu Y; Zhou H; Wang Y; Li W; Lu Z; Jiang Z; Gu X; Zheng H; Zeng L; Huang P; Zhang L; Gu X
Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707
[TBL] [Abstract][Full Text] [Related]
12. Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.
Zhang RL; Lo HH; Lei C; Ip N; Chen J; Law BY
Curr Opin Pharmacol; 2020 Oct; 54():72-81. PubMed ID: 32956895
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.
Shimizu C; Jain S; Davila S; Hibberd ML; Lin KO; Molkara D; Frazer JR; Sun S; Baker AL; Newburger JW; Rowley AH; Shulman ST; Burgner D; Breunis WB; Kuijpers TW; Wright VJ; Levin M; Eleftherohorinou H; Coin L; Popper SJ; Relman DA; Fury W; Lin C; Mellis S; Tremoulet AH; Burns JC
Circ Cardiovasc Genet; 2011 Feb; 4(1):16-25. PubMed ID: 21127203
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
[TBL] [Abstract][Full Text] [Related]
16. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
Hirabayashi Y; Takahashi Y; Xu Y; Akane K; Villalobos IB; Okuno Y; Hasegawa S; Muramatsu H; Hama A; Kato T; Kojima S
Eur J Pediatr; 2013 Jun; 172(6):833-7. PubMed ID: 23340699
[TBL] [Abstract][Full Text] [Related]
17. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
[TBL] [Abstract][Full Text] [Related]
18. Plasma clusterin concentrations may predict resistance to intravenous immunoglobulin in patients with Kawasaki disease.
Ou-Yang MC; Kuo HC; Lin IC; Sheen JM; Huang FC; Chen CC; Huang YH; Lin YJ; Yu HR
ScientificWorldJournal; 2013; 2013():382523. PubMed ID: 23956692
[TBL] [Abstract][Full Text] [Related]
19. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional Analysis of Intravenous Immunoglobulin Resistance in Kawasaki Disease Using an Induced Pluripotent Stem Cell Disease Model.
Ikeda K; Mizoro Y; Ameku T; Nomiya Y; Mae SI; Matsui S; Kuchitsu Y; Suzuki C; Hamaoka-Okamoto A; Yahata T; Sone M; Okita K; Watanabe A; Osafune K; Hamaoka K
Circ J; 2016 Dec; 81(1):110-118. PubMed ID: 27867156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
